Works matching Mantle cell lymphoma


Results: 3527
    1
    2
    3

    Addendum to British Society for Haematology Guideline for the management of mantle cell lymphoma, 2018 (Br. J. Haematol. 2018; 182: 46–62): Risk assessment of potential CAR T candidates receiving a covalent Bruton tyrosine kinase inhibitor for relapsed/refractory disease

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 1, p. 40, doi. 10.1111/bjh.18378
    By:
    • O'Reilly, Maeve A.;
    • Sanderson, Robin;
    • Wilson, William;
    • Iyengar, Sunil;
    • Lambert, Jonathan;
    • McCulloch, Rory;
    • Eyre, Toby A.
    Publication type:
    Article
    4
    5
    6
    7
    8

    Metástasis mamaria de linfoma de células del manto.

    Published in:
    Ginecología y Obstetricia de México, 2018, v. 86, n. 11, p. 740, doi. 10.24245/gom.v86i11.1979
    By:
    • Dardano-Berrie, Andrés;
    • Curbelo-Peña, Yuhamy;
    • Guerrero-López, Raúl;
    • Stickar, Tomas;
    • Gardenyes-Martínez, Julia;
    • Vallverdú-Cartie, Helena
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.

    Published in:
    International Journal of Cancer, 2021, v. 148, n. 1, p. 150, doi. 10.1002/ijc.33202
    By:
    • Roider, Tobias;
    • Wang, Xi;
    • Hüttl, Katrin;
    • Müller‐Tidow, Carsten;
    • Klapper, Wolfram;
    • Rosenwald, Andreas;
    • Stewart, James Peter;
    • Castro, David Gonzalez;
    • Dreger, Peter;
    • Hermine, Olivier;
    • Kluin‐Nelemans, Hanneke C.;
    • Grabe, Niels;
    • Dreyling, Martin;
    • Pott, Christiane;
    • Ott, German;
    • Hoster, Eva;
    • Dietrich, Sascha
    Publication type:
    Article
    29
    30
    31
    32
    33

    Smoldering mantle cell lymphoma.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0652-8
    By:
    • Haige Ye;
    • Desai, Aakash;
    • Dongfeng Zeng;
    • Nomie, Krystle;
    • Romaguera, Jorge;
    • Ahmed, Makhdum;
    • Wang, Michael L.
    Publication type:
    Article
    34

    SYNCHRONOUS MANTLE CELL LYMPHOMA OF LARYNX AND NASOPHARYNX.

    Published in:
    Turkish Journal of Geriatrics / Türk Geriatri Dergisi, 2019, v. 22, n. 4, p. 504, doi. 10.31086/tjgeri.2020.129
    By:
    • KUMBUL, Yusuf Çağdaş;
    • TÜZ, Mustafa;
    • BİRCAN, Sema;
    • YASAN, Hasan;
    • SİVRİCE, Mehmet Emre;
    • AKIN, Vural
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma.

    Published in:
    British Journal of Haematology, 2020, v. 191, n. 5, p. e103, doi. 10.1111/bjh.17063
    By:
    • Obr, Ales;
    • Klener, Pavel;
    • Furst, Tomas;
    • Kriegova, Eva;
    • Zemanova, Zuzana;
    • Urbankova, Helena;
    • Jirkuvova, Andrea;
    • Petrackova, Anna;
    • Malarikova, Diana;
    • Forsterova, Kristina;
    • Cudova, Barbora;
    • Sedlarikova, Lenka;
    • Berkova, Adela;
    • Kasalova, Nela;
    • Papajik, Tomas;
    • Trneny, Marek
    Publication type:
    Article
    50